Gap finder
Search review questions
Each row is one question a systematic review asked: who, what, compared with what, and which outcome, with the effect it found and how certain that is. Words match anywhere in the field.
1,518 questions in 135 reviews · Infectious Diseases
current versionsNo studies 135 · 8.9%Ungraded 150 · 9.9%Very low 350 · 23.1%Low 420 · 27.7%Moderate 321 · 21.1%High 142 · 9.4%
Ungraded means an effect was reported without a GRADE rating; it is not a gap. No studies means the review found nothing to answer the question. The six categories are a display order, not a score.
| Question | Effect | Evidence | Status / GRADE |
|---|---|---|---|
Intervention NR Length of hospital stay for inpatients · acute diarrhoea in children Racecadotril for acute diarrhoea in children (2019) · Cochrane | no estimate extracted | 2 studies · 224 participants | Low |
Intervention NR Adverse events: number of all types of adverse events · acute diarrhoea in children Racecadotril for acute diarrhoea in children (2019) · Cochrane | RR 0.9 [0.66, 1.22] | 5 studies · 688 participants | Low |
Intervention NR Death · children with severe malaria Artemether for severe malaria (2019) · Cochrane | RR 0.97 [0.77, 1.21] | 13 studies · 1659 participants | Moderate |
Intervention NR Fever clearance time · adults with severe malaria Artemether for severe malaria (2019) · Cochrane | no estimate extracted | 4 studies · 716 participants | Low |
Intervention NR Death · adults with severe malaria Artemether for severe malaria (2019) · Cochrane | RR 1.8 [1.09, 2.97] | 2 studies · 494 participants | Moderate |
Intervention NR Coma resolution time · adults with severe malaria Artemether for severe malaria (2019) · Cochrane | no estimate extracted | 2 studies · 494 participants | Moderate |
Intervention NR Neurological sequelae at discharge · adults with severe malaria Artemether for severe malaria (2019) · Cochrane | no estimate extracted | 0 studies · 0 participants | Ungraded |
Intervention NR Parasite clearance time · adults with severe malaria Artemether for severe malaria (2019) · Cochrane | no estimate extracted | 2 studies · 494 participants | Moderate |
Intervention NR Fever clearance time · adults with severe malaria Artemether for severe malaria (2019) · Cochrane | no estimate extracted | 2 studies · 494 participants | Moderate |
Intervention NR Coma resolution time · children with severe malaria Artemether for severe malaria (2019) · Cochrane | no estimate extracted | 6 studies · 358 participants | Low |
Intervention NR Neurological sequelae at discharge · children with severe malaria Artemether for severe malaria (2019) · Cochrane | RR 0.84 [0.66, 1.07] | 7 studies · 968 participants | Low |
Intervention NR Parasite clearance time · children with severe malaria Artemether for severe malaria (2019) · Cochrane | no estimate extracted | 7 studies · 420 participants | Moderate |
Intervention NR Fever clearance time · children with severe malaria Artemether for severe malaria (2019) · Cochrane | no estimate extracted | 8 studies · 457 participants | Low |
Intervention NR Death · adults with severe malaria Artemether for severe malaria (2019) · Cochrane | RR 0.59 [0.42, 0.83] | 4 studies · 716 participants | Moderate |
Intervention NR Coma resolution time · adults with severe malaria Artemether for severe malaria (2019) · Cochrane | no estimate extracted | 2 studies · 657 participants | Low |
Intervention NR Neurological sequelae at discharge · adults with severe malaria Artemether for severe malaria (2019) · Cochrane | RR 2.92 [0.31, 27.86] | 1 study · 560 participants | Low |
Intervention NR Parasite clearance time · adults with severe malaria Artemether for severe malaria (2019) · Cochrane | no estimate extracted | 4 studies · 716 participants | Moderate |
Intervention NR Diarrhoea prevalence Cluster RCTs · adults and children Interventions to improve disposal of child faeces for preventing diarrhoea and soil‐transmitted helminth… (2019) · Cochrane | RR 0.93 [0.84, 1.04] | 2 studies · 12040 participants | Low |
Intervention NR Diarrhoea incidence CBAs · adults and children Interventions to improve disposal of child faeces for preventing diarrhoea and soil‐transmitted helminth… (2019) · Cochrane | Rate ratio 0.77 [0.71, 0.84] | 2 studies · 1028 participants | Very low |
Intervention NR STH infection (any helminth) CBAs · adults and children Interventions to improve disposal of child faeces for preventing diarrhoea and soil‐transmitted helminth… (2019) · Cochrane | OR 0.17 [0.02, 0.73] | 1 study · 99 participants | Very low |
Intervention NR Diarrhoea Case‐control studies: child faeces disposal in latrine · adults and children Interventions to improve disposal of child faeces for preventing diarrhoea and soil‐transmitted helminth… (2019) · Cochrane | OR 0.73 [0.62, 0.85] | 17 studies · 32957 participants | Very low |
Intervention NR Diarrhoea Case‐control studies: defecation of children in latrine · adults and children Interventions to improve disposal of child faeces for preventing diarrhoea and soil‐transmitted helminth… (2019) · Cochrane | OR 0.54 [0.33, 0.9] | 7 studies · 2996 participants | Very low |
Intervention NR Diarrhoea incidence Cluster RCTs · adults and children Interventions to improve disposal of child faeces for preventing diarrhoea and soil‐transmitted helminth… (2019) · Cochrane | Rate ratio 0.71 [0.59, 0.86] | 2 studies · 2549 participants | Low |
Intervention NR Diarrhoea prevalence Controlled cohort studies: Sanitation Hygiene Education and Water Supply in Bangladesh (SHEWA‐B) intervention · adults and children Interventions to improve disposal of child faeces for preventing diarrhoea and soil‐transmitted helminth… (2019) · Cochrane | RR 0.91 [0.64, 1.28] | 2 studies · 2000 participants | Very low |
Intervention NR Diarrhoea prevalence Controlled cross‐sectional studies: Health Extension Package intervention (Ethiopia) · adults and children Interventions to improve disposal of child faeces for preventing diarrhoea and soil‐transmitted helminth… (2019) · Cochrane | OR 0.26 [0.16, 0.42] | 2 studies · 1660 participants | Very low |
Intervention NR Diarrhoea prevalence RCTs · adults and children Interventions to improve disposal of child faeces for preventing diarrhoea and soil‐transmitted helminth… (2019) · Cochrane | RR 0.92 [0.79, 1.07] | 4 studies · 16033 participants | Moderate |
Intervention NR STH infection (any helminth) RCTs · adults and children Interventions to improve disposal of child faeces for preventing diarrhoea and soil‐transmitted helminth… (2019) · Cochrane | RR 1.03 [0.64, 1.65] | 2 studies · 3480 participants | Low |
Intervention NR STH infection (any helminth) Controlled cross‐sectional study · adults and children Interventions to improve disposal of child faeces for preventing diarrhoea and soil‐transmitted helminth… (2019) · Cochrane | RR 2.51 [1.74, 3.62] | 1 study · 341 participants | Very low |
Intervention NR Diarrhoea prevalence RCTs · adults and children Interventions to improve disposal of child faeces for preventing diarrhoea and soil‐transmitted helminth… (2019) · Cochrane | RR 0.79 [0.49, 1.26] | 2 studies · 9558 participants | Very low |
Intervention NR Diarrhoea prevalence RCTs · adults and children Interventions to improve disposal of child faeces for preventing diarrhoea and soil‐transmitted helminth… (2019) · Cochrane | RR 1.15 [0.93, 1.41] | 1 study · 3650 participants | Very low |
Intervention NR Test result Lateral flow urine lipoarabinomannan assay for detecting active tuberculosis in people living with HIV (2019) · Cochrane | no estimate extracted | NR | No studies |
Intervention NR False positives Lateral flow urine lipoarabinomannan assay for detecting active tuberculosis in people living with HIV (2019) · Cochrane | no estimate extracted | NR | No studies |
Intervention NR True positives Lateral flow urine lipoarabinomannan assay for detecting active tuberculosis in people living with HIV (2019) · Cochrane | no estimate extracted | NR | No studies |
Intervention NR False negatives Lateral flow urine lipoarabinomannan assay for detecting active tuberculosis in people living with HIV (2019) · Cochrane | no estimate extracted | NR | No studies |
Intervention NR True negatives Lateral flow urine lipoarabinomannan assay for detecting active tuberculosis in people living with HIV (2019) · Cochrane | no estimate extracted | NR | No studies |
Intervention NR False positives Lateral flow urine lipoarabinomannan assay for detecting active tuberculosis in people living with HIV (2019) · Cochrane | no estimate extracted | NR | No studies |
Intervention NR Test result Lateral flow urine lipoarabinomannan assay for detecting active tuberculosis in people living with HIV (2019) · Cochrane | no estimate extracted | NR | No studies |
Intervention NR True positives Lateral flow urine lipoarabinomannan assay for detecting active tuberculosis in people living with HIV (2019) · Cochrane | no estimate extracted | NR | No studies |
Intervention NR False negatives Lateral flow urine lipoarabinomannan assay for detecting active tuberculosis in people living with HIV (2019) · Cochrane | no estimate extracted | NR | No studies |
Intervention NR True negatives Lateral flow urine lipoarabinomannan assay for detecting active tuberculosis in people living with HIV (2019) · Cochrane | no estimate extracted | NR | No studies |
Intervention NR Malaria incidence · people at risk of malaria Larviciding to prevent malaria transmission (2019) · Cochrane | Rate ratio 0.24 | 4649 participants | Low |
Intervention NR Parasite prevalence · people at risk of malaria Larviciding to prevent malaria transmission (2019) · Cochrane | RR 0.26 | 5868 participants | Low |
Intervention NR Malaria incidence · people at risk of malaria Larviciding to prevent malaria transmission (2019) · Cochrane | RR 1.58 [0.94, 2.65] | 1793 participants | Very low |
Intervention NR Parasite prevalence · people at risk of malaria Larviciding to prevent malaria transmission (2019) · Cochrane | RR 1.15 [0.41, 3.2] | 3574 participants | Very low |
Intervention NR Test result · HIV‐positive individuals Abdominal ultrasound for diagnosing abdominal tuberculosis or disseminated tuberculosis with abdominal… (2019) · Cochrane | no estimate extracted | NR | No studies |
Intervention NR True positives (participants correctly classified as having tuberculosis) · HIV‐positive individuals Abdominal ultrasound for diagnosing abdominal tuberculosis or disseminated tuberculosis with abdominal… (2019) · Cochrane | no estimate extracted | 368 participants | Very low |
Intervention NR False negatives (participants incorrectly classified as not having tuberculosis) · HIV‐positive individuals Abdominal ultrasound for diagnosing abdominal tuberculosis or disseminated tuberculosis with abdominal… (2019) · Cochrane | no estimate extracted | 368 participants | Very low |
Intervention NR True negatives (participants correctly classified as not having tuberculosis) · HIV‐positive individuals Abdominal ultrasound for diagnosing abdominal tuberculosis or disseminated tuberculosis with abdominal… (2019) · Cochrane | no estimate extracted | 511 participants | Very low |
Intervention NR False positives (participants incorrectly classified as having tuberculosis) · HIV‐positive individuals Abdominal ultrasound for diagnosing abdominal tuberculosis or disseminated tuberculosis with abdominal… (2019) · Cochrane | no estimate extracted | 511 participants | Very low |
Linezolid vs no linezolid Death · drug‐resistant pulmonary tuberculosis Linezolid for drug‐resistant pulmonary tuberculosis (2019) · Cochrane | RR 0.65 [0.12, 3.62] | 1 study · 65 participants | Very low |